Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 15/20 | 0.54 |
| ▸ | FNTB | P49356 | 15/20 | 0.54 |
| ▸ | PGGT1B | P53609 | 13/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | NPY4R | P50391 | 3/20 | 0.44 |
| ▸ | NPY1R | P25929 | 2/20 | 0.44 |
| ▸ | NPY2R | P49146 | 2/20 | 0.44 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15011155 | 1.00 | FNTA (0.54) | FNTAFNTBPGGT1BLMNANPY4R | |
| SCHEMBL9189133 | 1.00 | FNTA (0.54) | FNTAFNTBPGGT1BLMNANPY4R | |
| SCHEMBL29527234 | 0.95 | FNTA (0.51) | FNTAFNTBPGGT1BLMNANPY4R | |
| SCHEMBL31122838 | 0.94 | FNTA (0.49) | FNTAFNTBPGGT1BLMNANPY4R | |
| SCHEMBL30479333 | 0.94 | FNTA (0.51) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL30123035 | 0.93 | FNTA (0.48) | FNTAFNTBPGGT1BLMNANPY4R | |
| SCHEMBL30761725 | 0.93 | FNTA (0.49) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL31643025 | 0.92 | FNTA (0.49) | FNTAFNTBPGGT1B | |
| SCHEMBL29655708 | 0.92 | FNTA (0.47) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL30463271 | 0.91 | FNTA (0.49) | FNTAFNTBPGGT1BNPY4RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025002589-A1 | TISSUE EXTRACELLULAR PEPTIDE PATTERNS DEDICATED FOR GENERATION OF ANTI-CANCER VACCINES AGAINST SALIVARY GLAND TUMOR, IDENTIFICATION AND ISOLATION OF SALIVARY GLAND TUMOR SPECIFIC T CELLS IN HUMANS | Uniwersytet Gdański (PL) | 2025-01-02 | — | — | WO | claimed |
| CN-113804901-B | Serum lipid marker for early noninvasive diagnosis of oral squamous carcinoma and application thereof | 南京市口腔医院 | 2023-06-23 | — | — | CN | claimed |
| CN-113804901-A | Serum lipid marker for early noninvasive diagnosis of oral squamous cell carcinoma and application thereof | 南京市口腔医院 | 2021-12-17 | — | — | CN | claimed |
| EP-0666729-A1 | COSMETIC COMPOSITION | UNILEVER PLC (GB) | 1995-08-16 | — | — | EP | claimed |
| WO-1994009750-A1 | COSMETIC COMPOSITION | UNILEVER PLC (GB) | 1994-05-11 | — | — | WO | claimed |
| EP-4515229-A1 | BIOSENSOR TESTING SYSTEM AND METHODS OF USE | QUIDEL CORPORATION (US) | 2025-03-05 | — | — | EP | disclosed |
| WO-2025002589-A1 | TISSUE EXTRACELLULAR PEPTIDE PATTERNS DEDICATED FOR GENERATION OF ANTI-CANCER VACCINES AGAINST SALIVARY GLAND TUMOR, IDENTIFICATION AND ISOLATION OF SALIVARY GLAND TUMOR SPECIFIC T CELLS IN HUMANS | Uniwersytet Gdański (PL) | 2025-01-02 | — | — | WO | disclosed |
| US-20240368619-A1 | METHODS AND COMPOSITIONS FOR PPO HERBICIDE TOLERANCE | DLF SEEDS (DK) | 2024-11-07 | — | — | US | disclosed |
| US-20240315296-A1 | PEPTIDE COMPOUNDS FOR FLAVOR MODULATING | CJ CHEILJEDANG CORPORATION (KR) | 2024-09-26 | — | — | US | disclosed |
| CN-115836724-B | Soy sauce rich in salty peptide and preparation method thereof | 佛山市海天(高明)调味食品有限公司 | 2024-05-31 | — | — | CN | disclosed |
| EP-4364582-A1 | PEPTIDE COMPOUNDS FOR FLAVOR MODULATING | CJ Cheiljedang Corporation (KR) | 2024-05-08 | — | — | EP | disclosed |
| WO-2023212728-A1 | BIOSENSOR TESTING SYSTEM AND METHODS OF USE | QUIDEL CORPORATION (US) | 2023-11-02 | — | — | WO | disclosed |
| WO-2013086365-A2 | BIOMARKERS FOR KIDNEY CANCER AND METHODS USING THE SAME | METABOLON, INC. (US) | 2013-06-13 | — | — | WO | disclosed |
| US-20110262962-A1 | METHOD FOR PRODUCING PEPTIDES | AJINOMOTO CO., INC. (JP) | 2011-10-27 | — | — | US | disclosed |
| US-20070292916-A1 | MUTANT PROTEIN HAVING THE PEPTIDE-SYNTHESIZING ACTIVITY | AJINOMOTO CO., INC. (JP) | 2007-12-20 | — | — | US | disclosed |
| EP-1829968-A1 | MUTANT PROTEIN HAVING PEPTIDE-PRODUCTION ACTIVITY | Ajinomoto Co., Inc. (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-20070190602-A1 | Mutant protein having the peptide-synthesizing activity | AJINOMOTO CO., INC (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20060188976-A1 | Mutant protein having the peptide-synthesizing activity | AJINOMOTO CO. INC (JP) | 2006-08-24 | — | — | US | disclosed |
| EP-0666729-A1 | COSMETIC COMPOSITION | UNILEVER PLC (GB) | 1995-08-16 | — | — | EP | disclosed |
| WO-1994009750-A1 | COSMETIC COMPOSITION | UNILEVER PLC (GB) | 1994-05-11 | — | — | WO | disclosed |